Category Archives: Healthcare

miRagen Therapeutics Inc Receives a Buy from Wedbush

In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on miRagen Therapeutics Inc (NASDAQ: MGEN). The company’s shares opened today at $9.10. According to TipRanks.com, Moussatos is a 4-star analyst with an average return of 7.5%

Nektar Therapeutics Receives a Buy from Jefferies

In a report issued on August 16, David Steinberg from Jefferies reiterated a Buy rating on Nektar Therapeutics (NASDAQ: NKTR), with a price target of $23. The company’s shares opened today at $18.28. According to TipRanks.com, Steinberg is a 4-star

Analysts Offer Insights on Healthcare Companies: Pfizer (NYSE: PFE), Immunomedics (NASDAQ: IMMU) and Tesaro (NASDAQ: TSRO)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pfizer (NYSE: PFE), Immunomedics (NASDAQ: IMMU) and Tesaro (NASDAQ: TSRO). Pfizer (NYSE: PFE) Jefferies analyst David Steinberg reiterated a Hold rating on Pfizer

TherapeuticsMD Gets a Buy Rating from Oppenheimer

In a report released today, Jay Olson from Oppenheimer reiterated a Buy rating on TherapeuticsMD (NYSE MKT: TXMD), with a price target of $10. The company’s shares opened today at $6.27. Olson noted: “TXMD is collaborating with the FDA on

Cantor Fitzgerald Thinks Opko Health’s Stock is Going to Recover

Cantor Fitzgerald analyst Louise Chen initiated coverage with a Buy rating on Opko Health (NYSE: OPK) today and set a price target of $20. The company’s shares opened today at $6.03, close to its 52-week high of $12.15. Chen noted:

H.C. Wainwright Sticks to Their Buy Rating for Pluristem

In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on Pluristem (NASDAQ: PSTI), with a price target of $3.50. The company’s shares closed yesterday at $1.19. According to TipRanks.com, Ramakanth is ranked 0 out of